Serevent(TM) significantly increases trough FEV(1) in COPD up to 12 months without loss of effect

Robert Stockley, PJ Whitehead, MK Williams, G Hagan

Research output: Contribution to conference (unpublished)Paper

Original languageEnglish
PagesA95
Publication statusPublished - 1 Jan 2003

Cite this